Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2018

01-03-2018 | Original Article

RETRACTED ARTICLE: The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies

Authors: Ruifei Yang, Liang Yao, Yuan Fang, Jing Sun, Tiankang Guo, Kehu Yang, Limin Tian

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2018

Login to get access

Abstract

Our aim was to assess the risk of fractures or low bone mineral density (BMD) associated with subclinical thyroid dysfunction among cohorts. We systematically searched Medline (via PubMed), EMBASE, Cochrane Library, Web of Science, CENTRAL and SinoMed up to 31 July 2016 to identify cohort studies which have analyzed associations between subclinical thyroid dysfunction and fracture or BMD. A total of 19 population-based cohorts including 79,368 participants with relationships between subclinical thyroid dysfunction and fractures or BMD were identified as eligible for this meta-analysis. Subclinical hypothyroidism was associated with relative risks (RRs) of 1.34 (95% confidence interval [CI] 1.14, 1.58; I 2 = 32%) for hip fracture, 1.27 (95% CI 1.02, 1.58; I 2 = 51.9%) for any location of fracture, and 1.25 (95% CI 1.04, 1.50) for forearm fracture. Subclinical hyperthyroidism was associated with RRs of 1.71 (95% CI 1.06, 2.76; I 2 = 0.0%) for spine fracture, 1.20 (95% CI 1.03, 1.39; I 2 = 0.0%) for non-spine fracture, 1.44 (95% CI 1.21, 1.71; I 2 = 0.0%) for hip fracture, and 1.38 (95% CI 1.21, 1.58; I 2 = 0.0%) for any location of fracture. Subgroup analysis was conducted according to whether thyroid/anti-thyroid drug users were excluded or not and the results were similar. The change in BMD at the hip (weighted mean difference [WMD] = −0.060, 95% CI −0.116, −0.004; I 2 = 0.0%) and femoral neck (WMD = −0.046, 95% CI −0.077, −0.015; I 2 = 0.0%) was significantly decreased in the subclinical hyperthyroidism group compared with the euthyroidism groups in females. We failed to find any associations between the change in BMD and subclinical hypothyroidism. The overall quality of evidence was low in all outcomes. Subclinical hyperthyroidism and subclinical hypothyroidism were associated with an increased risk of fractures. Although subclinical hyperthyroidism was related to reduced BMD, no evidence could prove a definite association between subclinical hypothyroidism and the risk of low BMD.
Literature
1.
go back to reference Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288:1889–1897CrossRef Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288:1889–1897CrossRef
2.
go back to reference Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581–589CrossRef Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581–589CrossRef
3.
go back to reference Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:1344–1351CrossRef Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:1344–1351CrossRef
4.
go back to reference National Osteoporosis Foundation (2002). America’s bone Health: the state of osteoporosis and low bone mass in our nation. National Osteoporosis Foundation, Washington, DC National Osteoporosis Foundation (2002). America’s bone Health: the state of osteoporosis and low bone mass in our nation. National Osteoporosis Foundation, Washington, DC
5.
go back to reference Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral and fracture risk−a meta-analysis. Thyroid 13:585–593CrossRef Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral and fracture risk−a meta-analysis. Thyroid 13:585–593CrossRef
7.
go back to reference Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM (2006) Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:426–432CrossRef Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM (2006) Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:426–432CrossRef
8.
go back to reference Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419CrossRef Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419CrossRef
9.
go back to reference Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76–131CrossRef Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76–131CrossRef
10.
go back to reference Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:E1–E8CrossRef Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:E1–E8CrossRef
11.
go back to reference Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041CrossRef Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041CrossRef
12.
go back to reference Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR (2012) Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 97:3944–3950CrossRef Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR (2012) Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 97:3944–3950CrossRef
13.
go back to reference Lee WY, Oh KW, Rhee EJ, Jung CH, Kim SW, Yun EJ, Tae HJ, Baek KH, Kang MI, Choi MG, Yoo HJ, Park SW (2006) Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch Med Res 37:511–516CrossRef Lee WY, Oh KW, Rhee EJ, Jung CH, Kim SW, Yun EJ, Tae HJ, Baek KH, Kang MI, Choi MG, Yoo HJ, Park SW (2006) Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch Med Res 37:511–516CrossRef
14.
go back to reference Nagata M, Suzuki A, Sekiguchi S, Ono Y, Nishiwaki-Yasuda K, Itoi T, Yamamoto S, Imamura S, Katoh T, Hayakawa N, Oda N, Hashimoto S, Itoh M (2007) Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women. Endocr J 54:625–630CrossRef Nagata M, Suzuki A, Sekiguchi S, Ono Y, Nishiwaki-Yasuda K, Itoi T, Yamamoto S, Imamura S, Katoh T, Hayakawa N, Oda N, Hashimoto S, Itoh M (2007) Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women. Endocr J 54:625–630CrossRef
15.
go back to reference Saler T, Ahbab S, Sağlam ZA, Keşkek ŞÖ, Kurnaz S (2014) Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women. Hippokratia 18:240–244PubMedPubMedCentral Saler T, Ahbab S, Sağlam ZA, Keşkek ŞÖ, Kurnaz S (2014) Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women. Hippokratia 18:240–244PubMedPubMedCentral
16.
go back to reference Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, Bronfort G, van Tulder MW, Editorial Board of the Cochrane Back, Neck Group (2015) 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine (Phila Pa 1976) 40:1660–1673CrossRef Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, Bronfort G, van Tulder MW, Editorial Board of the Cochrane Back, Neck Group (2015) 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine (Phila Pa 1976) 40:1660–1673CrossRef
17.
go back to reference Zhang YJ (2009) Clinical analysis of clinical and subclinical hyperthyroidism in patients with bone mineral density. Neimeng Med J 4:434–437 Zhang YJ (2009) Clinical analysis of clinical and subclinical hyperthyroidism in patients with bone mineral density. Neimeng Med J 4:434–437
18.
go back to reference Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjøro T, Langhammer A (2013) Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol 169:845–852CrossRef Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjøro T, Langhammer A (2013) Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol 169:845–852CrossRef
19.
go back to reference Bertoli A, Fusco A, Andreoli A, Magnani A, Tulli A, Lauro D, De Lorenzo A (2002) Effect of subclinical hypothyroidism and obesity on whole-body and regional bone mineral content. Horm Res 57:79–84PubMed Bertoli A, Fusco A, Andreoli A, Magnani A, Tulli A, Lauro D, De Lorenzo A (2002) Effect of subclinical hypothyroidism and obesity on whole-body and regional bone mineral content. Horm Res 57:79–84PubMed
20.
go back to reference Waring AC, Harrison S, Fink HA, Samuels MH, Cawthon PM, Zmuda JM, Orwoll ES, Bauer DC, Osteoporotic Fractures in Men (MrOS) Study (2013) A prospective study of thyroid function, bone loss, and fractures in older men: the MrOS study. J Bone Miner Res 28:472–479CrossRef Waring AC, Harrison S, Fink HA, Samuels MH, Cawthon PM, Zmuda JM, Orwoll ES, Bauer DC, Osteoporotic Fractures in Men (MrOS) Study (2013) A prospective study of thyroid function, bone loss, and fractures in older men: the MrOS study. J Bone Miner Res 28:472–479CrossRef
21.
go back to reference Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R (2008) The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid 18:1147–1155CrossRef Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R (2008) The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid 18:1147–1155CrossRef
22.
go back to reference Finigan J, Greenfield DM, Blumsohn A, Hannon RA, Peel NF, Jiang G, Eastell R (2008) Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women. J Bone Miner Res 23:5–85 Finigan J, Greenfield DM, Blumsohn A, Hannon RA, Peel NF, Jiang G, Eastell R (2008) Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women. J Bone Miner Res 23:5–85
23.
go back to reference Bauer DC, Ettinger B, Nevitt MC, Stone KL, Study of Osteoporotic Fractures Research G (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568CrossRef Bauer DC, Ettinger B, Nevitt MC, Stone KL, Study of Osteoporotic Fractures Research G (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568CrossRef
24.
go back to reference Garin MC, Arnold AM, Lee JS, Robbins J, Cappola AR (2014) Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study. J Clin Endocrinol Metab 99:2657–2664CrossRef Garin MC, Arnold AM, Lee JS, Robbins J, Cappola AR (2014) Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study. J Clin Endocrinol Metab 99:2657–2664CrossRef
25.
go back to reference Lee JS, Buzková P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR, Robbins J. (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 170:1876–1883CrossRef Lee JS, Buzková P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR, Robbins J. (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 170:1876–1883CrossRef
26.
go back to reference Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, Wareham NJ, Khaw KT (2010) Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol 72:404–410CrossRef Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, Wareham NJ, Khaw KT (2010) Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol 72:404–410CrossRef
27.
go back to reference Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW,Uitterlinden AG, Vernooij MW (2013) The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28:889–926CrossRef Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW,Uitterlinden AG, Vernooij MW (2013) The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28:889–926CrossRef
28.
go back to reference Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466CrossRef Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466CrossRef
29.
go back to reference Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW, Mooijaart SP, Rodondi N, de Craen AJ, PROSPER Group (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 97:852–861CrossRef Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW, Mooijaart SP, Rodondi N, de Craen AJ, PROSPER Group (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 97:852–861CrossRef
30.
go back to reference Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472CrossRef Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472CrossRef
31.
go back to reference Murphy E, Glüer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR (2010) Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 95:3173–3181CrossRef Murphy E, Glüer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR (2010) Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 95:3173–3181CrossRef
32.
go back to reference Ceresini G, Ceda GP, Lauretani F, Maggio M, Usberti E, Marina M, Bandinelli S, Guralnik JM, Valenti G, Ferrucci L (2013) Thyroid status and 6-year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area Study. J Am Geriatr Soc 61:868–874CrossRef Ceresini G, Ceda GP, Lauretani F, Maggio M, Usberti E, Marina M, Bandinelli S, Guralnik JM, Valenti G, Ferrucci L (2013) Thyroid status and 6-year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area Study. J Am Geriatr Soc 61:868–874CrossRef
33.
go back to reference Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591–2599CrossRef Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591–2599CrossRef
34.
go back to reference Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154CrossRef Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154CrossRef
35.
go back to reference Mendonça Monteiro de Barros G, Madeira M, Vieira Neto L, de Paula Paranhos Neto F, Carvalho Mendonça LM, Corrêa Barbosa Lima I, Corbo R, Fleiuss Farias ML (2016) Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients. J Bone Miner Metab 34:417–421CrossRef Mendonça Monteiro de Barros G, Madeira M, Vieira Neto L, de Paula Paranhos Neto F, Carvalho Mendonça LM, Corrêa Barbosa Lima I, Corbo R, Fleiuss Farias ML (2016) Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients. J Bone Miner Metab 34:417–421CrossRef
36.
go back to reference Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, Yuen T, Blair HC, Zaidi M, Davies TF (2012) Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Investig 122:3737–3741CrossRef Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, Yuen T, Blair HC, Zaidi M, Davies TF (2012) Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Investig 122:3737–3741CrossRef
37.
go back to reference Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS (2006) The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid 16:375–380CrossRef Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS (2006) The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid 16:375–380CrossRef
38.
go back to reference Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356CrossRef Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356CrossRef
39.
go back to reference Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289PubMed Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289PubMed
40.
go back to reference Toft AD (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345:512–516CrossRef Toft AD (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345:512–516CrossRef
41.
go back to reference Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152:1–9CrossRef Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152:1–9CrossRef
42.
go back to reference Bassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R, Archanco M, Flamant F, Samarut J, Costagliola S, Vassart G, Weiss RE, Refetoff S, Williams GR (2008) A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 22:501–512CrossRef Bassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R, Archanco M, Flamant F, Samarut J, Costagliola S, Vassart G, Weiss RE, Refetoff S, Williams GR (2008) A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 22:501–512CrossRef
43.
go back to reference Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES (2009) Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 20:715–722CrossRef Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES (2009) Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 20:715–722CrossRef
44.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283:2008–2012CrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283:2008–2012CrossRef
45.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L (2005) Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77:139–144CrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77:139–144CrossRef
46.
go back to reference Ko YJ, Kim JY, Lee J, Song HJ, Kim JY, Choi NK, Park BJ (2014) Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women. J Prev Med Public Health 47:6–46CrossRef Ko YJ, Kim JY, Lee J, Song HJ, Kim JY, Choi NK, Park BJ (2014) Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women. J Prev Med Public Health 47:6–46CrossRef
Metadata
Title
RETRACTED ARTICLE: The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies
Authors
Ruifei Yang
Liang Yao
Yuan Fang
Jing Sun
Tiankang Guo
Kehu Yang
Limin Tian
Publication date
01-03-2018
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2018
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-017-0828-5

Other articles of this Issue 2/2018

Journal of Bone and Mineral Metabolism 2/2018 Go to the issue